Effects of Tadalafil on LMR and MHR in Patients With ED

Samsun Liv Hospital

Status

Completed

Conditions

Inflammation

Erectile Dysfunction

Treatments

Drug: Tadalafil 5mg tablet

Study type

Observational

Funder types

Other

Identifiers

NCT03918993

OMU KAEK 2019/158

Details and patient eligibility

About

The aim of the study was to investigate whether daily 5 mg tadalafil over eight weeks affects to Lymphocyte/Monocyte ratio (LMR) and Monocyte/High-Density Lipoprotein ratio (MHR) in patients with erectile dysfunction (ED).

Thirty-one patients with organic ED and 31 healthy controls between July 2017 and November 2018 were included in this retrospective study. To avoid bias, the patients were randomly selected and the controls were also incorporated consecutively. The presence of ED was determined according to the International Erectile Function Index-5 (IIEF-5). The patients and the controls were evaluated in terms of IIEF-5, complete blood count, serum biochemistry, LMR, and MHR.

Full description

The medical records of the heterosexual men treated with the diagnosis of organic ED in the Urology department of a private hospital between July 2017 and October 2018 were evaluated retrospectively. The number of samples to be included in the study was determined by the help of the computer-assisted power analysis. Random sampling was performed from all cohorts of patients with ED. Thirty-one male patients between the ages of 39-65 with organic erectile dysfunction more than one year and treated with OAD 5 mg dose of tadalafil for eight weeks were selected as the treatment group (group T)The patients in group T have been assessed both before (T1) and after (T2) the treatment.

Between the ages of 39-65, thirty-one healthy men who were admitted to the internal medicine outpatient clinic for their annual follow-up were selected consecutively and the control group (group C) was formed. All subjects in the control group were sexually active men with regular monogamous heterosexual relationships during the last one year.

Enrollment

62 patients

Sex

Male

Ages

39 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

39-65 years old men with ED
39-65 years old, haelthy men
Patients that have received 5 mg tadalafil/day for 8 weeks
Patients with informed consent forms
Patients with no missing variables

Exclusion criteria

Patients with systemic autoimmune and inflammatory disease,
congestive heart failure,
chronic renal failure, and chronic hepatobiliary disease,
chronic lung disease, and thyroid dysfunction,
patients with acute infection,
patients with neurological deficits,
metabolic syndrome and malignancy
Patients with a history of prostate, penile or pelvic surgery or radiotherapy,,
patients receiving anticoagulant, beta-blocker, antidepressants and antipsychotics, hormonal therapy,
patients with alcohol and smoking